Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Co-occurring Cocaine and Opioid Use Disorders
NCT03016598Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2018
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in stimulant use disorder (SUD), sponsored by VA Office of Research & Development. Started Jan 2018; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
stimulant use disorder (SUD)
Beyond the preview
Go deeper on NCT03016598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03016598.